Redox interactions of nitric oxide with dopamine and its derivatives

被引:43
作者
Antunes, F [1 ]
Nunes, C
Laranjinha, J
Cadenas, E
机构
[1] Univ Lisbon, Ctr Quim & Bioquim, Inst Invest Cientif Bento Rocha Cabral, P-1699 Lisbon, Portugal
[2] Univ Lisbon, Ctr Quim & Bioquim, Grp Bioquim Oxidantes & Antioxidantes, P-1699 Lisbon, Portugal
[3] Univ Coimbra, Fac Pharm, P-3000 Coimbra, Portugal
[4] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal
[5] Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA
关键词
Parkinson's disease; DOPAC; mitochondria; storage vesicles; oxidative stress; free radicals;
D O I
10.1016/j.tox.2004.11.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitric oxide ((NO)-N-.) is a ubiquitous diffusible messenger in the central nervous system. (NO)-N-. and derived nitrogen species may interact with catecholamines, thus, modifying not only its regulatory actions but also producing oxidants and free radicals that are likely to trigger toxic pathways in the nervous system. Oxidative pathways and chain oxidation reactions triggered by catecholamines may be broken by ascorbate and glutathione, of which there is ample supply in the brain. At the subcellular level, mitochondria. and cytosolic dopamine storage vesicles are likely to provide site-specific settings for (NO)-N-. and catecholamines interactions. Thus, a complex picture emerges in which the steady- state levels of the individual reactants, the rate constants of the reactions involved, the oxygen tension, and the compartmentalization of reactions determine the biological significance of the redox. interactions between (NO)-N-. and dopamine metabolism in the brain. The physiological relevance of (NO)-N-.-driven chemical modifications of dopamine and its derivatives and the ensuing free radical production are discussed in connection with the neurodegeneration inherent in Parkinson's disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 27 条
[1]  
AMBROZIAK W, 1991, J BIOL CHEM, V266, P13011
[2]   Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells [J].
Antunes, F ;
Han, D ;
Rettori, D ;
Cadenas, E .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2002, 1556 (2-3) :233-238
[3]   DOPAMINE NEUROTOXICITY - INHIBITION OF MITOCHONDRIAL RESPIRATION [J].
BENSHACHAR, D ;
ZUK, R ;
GLINKA, Y .
JOURNAL OF NEUROCHEMISTRY, 1995, 64 (02) :718-723
[4]   Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[5]  
Boveris A, 2000, ANN NY ACAD SCI, V899, P121
[6]  
BRAUTIGAM M, 1985, ARZNEIMITTEL-FORSCH, V35, P277
[7]   REDOX AND ADDITION CHEMISTRY OF QUINOID COMPOUNDS AND ITS BIOLOGICAL IMPLICATIONS [J].
BRUNMARK, A ;
CADENAS, E .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 7 (04) :435-477
[8]  
CARMICHAEL SW, 1978, CELL TISSUE RES, V191, P421
[9]   Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide [J].
Daveu, C ;
Servy, C ;
Dendane, M ;
Marin, P ;
Ducrocq, C .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1997, 1 (03) :234-243
[10]   Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease [J].
Ebadi, M ;
Sharma, SK .
ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (03) :319-335